Manipal Health Enterprises Limited vs Torrent Pharmaceuticals Limited

A side-by-side comparison of Manipal Health Enterprises Limited (MANIPALHOS) and Torrent Pharmaceuticals Limited (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Torrent Pharmaceuticals Limited leads MANIPALHOS vs TORNTPHARM on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

48.81
P/E ratio
77.03
5.22
P/B ratio
18.67
0.00%
Dividend yield
0.77%
₹13.89
EPS
₹63.92

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

11.80%
Return on equity
27.40%
12.00%
Return on capital
15.00%
27.00%
EBITDA margin
33.00%
17.24%
Net margin
15.29%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

63.48%
Revenue CAGR (3Y)
13.27%
67.79%
Profit CAGR (3Y)
19.75%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹89,104 Cr
Market cap
₹1.88L Cr
₹3,104 Cr
Revenue
₹13,980 Cr
₹535 Cr
Net profit
₹2,138 Cr
1.35
Debt / equity
1.69
Manipal Health Enterprises Limited
  • ["Company has a low return on equity of 10.3% over last 3 years."]
Torrent Pharmaceuticals Limited
  • + ["Company is expected to give good quarter", "Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • ["Stock is trading at 19.9 times its book value", "Promoter holding has decreased over last quarter: -7.53%", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
Manipal Health Enterprises Limited full analysis Torrent Pharmaceuticals Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

MANIPALHOS vs TORNTPHARM: Share Price, Valuation & Which to Buy | DocStoX